Received Sep 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Y013348 | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | — | — |
No additional AE; Customer called to report TE. VARIVAX was administered to on patient on 08/28/2025.; This spontaneous report was received from an office manager and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 28-AUG-2025, the patient was vaccinated with an improperly stored (8 F for 46 hours, no previous temperature excursions) varicella virus vaccine live (oka-merck) (VARIVAX) injection at a total dose of 0.5 mL, lot #Y013348, expiration date: 02-AUG-2026, administered for prophylaxis (route of administration and anatomical location were not reported) (Product storage error). The vaccine was reconstituted with sterile diluent (lot# and expiration date not reported). No additional adverse event was reported.